Find SARS-CoV-2 related resources at NCBI. Download and submit sequences. Explore literature, identify clinical trials, and compounds used in them.
Feb 11, 2020 · ICTV announced “severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)” as the name of the new virus on 11 February 2020. This name was chosen because the virus is genetically related to the coronavirus responsible for the SARS outbreak of 2003. While related, the two viruses are different.
Jan 28, 2022 · Importantly, cannabigerolic acid and cannabidiolic acid were equally effective against the SARS-CoV-2 alpha variant B.1.1.7 and the beta variant B.1.351. Orally bioavailable and with a long history of safe human use, these cannabinoids, isolated or in hemp extracts, have the potential to prevent as well as treat infection by SARS-CoV-2.
Up-to-date SARS-CoV-2; SARS-CoV-2 Variants Overview; Help . How To; How to Participate . Partner with us; How to cite us? Scientific advisors; Become a tester! Submit Sequences . SARS-CoV-2; All other viruses; Contact Us
May 12, 2022 · As the emerging variants of SARS-CoV-2 continue to drive the worldwide pandemic, there is a constant demand for vaccines that offer more effective and broad-spectrum protection. Here, we report a circular RNA (circRNA) vaccine that elicited potent neutralizing antibodies and T cell responses by expr …
May 14, 2020 · SARS-CoV-2 is a betacoronavirus responsible for the COVID-19 pandemic. Although the SARS-CoV-2 genome was reported recently, its transcriptomic architecture is unknown. Utilizing two complementary sequencing techniques, we present a high-resolution map of the SARS-CoV-2 transcriptome and epitranscri …
Jul 09, 2022 · En este sitio web se puede encontrar información y orientaciones de la OMS acerca del actual brote de enfermedad por coronavirus (COVID-19) que fue notificado por primera vez en Wuhan (China) el 31 de diciembre de 2019.